Effect of a 5-lipoxygenase (5-LO)/cyclooxygenase (CO) inhibitor, WY-47, 288, on cutaneous models of inflammation

Agents and Actions
R P CarlsonJ Y Chang

Abstract

WY-47,288 (2-[(1-naphthalenyloxy)methyl]quinoline) demonstrated topical antiinflammatory activity in several animal models of skin inflammation. Application of WY-47,288 to mouse ear surfaces inhibited arachidonic acid (ED50 = 0.3 mg/ear) and tetradecanoylphorbol acetate (TPA)-induced inflammation (40% at 1 mg/ear). Administration of WY-47,288 (1 mg/ear) at 30 min and 5 h after TPA reduced ear edema and epidermal proliferation by 50%. WY-47,288 also inhibited oxazolone-induced contact hypersensitivity in mouse ears (ED50 = 0.4 mg/ear) and UVB-induced guinea pig skin erythema (ED50 approximately 0.25 mg/spot). These antiinflammatory effects may be due to inhibition of 5-lipoxygenase (5-LO) and cyclooxygenase (CO) since the synthesis of 5-LO and CO products by rat neutrophils and mouse macrophages was dose-dependently reduced by WY-47,288. By contrast, WY-47,288 demonstrated no appreciable inhibition of 12-LO (rabbit platelet), 15-LO (soybean) or phospholipase A2 (human platelet). Furthermore, no systemic adverse effects were observed after topical, parenteral or oral administration of WY-47,288, suggesting that WY-47,288 is a safe topical 5-LO/CO inhibitor for treating skin inflammation.

References

Dec 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·S HammarströmJ J Voorhees
Apr 1, 1987·British Medical Bulletin·J A Salmon, G A Higgs
Apr 1, 1987·British Medical Bulletin·R D Camp, M W Greaves
Jul 1, 1985·The British Journal of Dermatology·K KragballeJ J Voorhees
Oct 1, 1985·The Journal of Investigative Dermatology·C C ChanA Ford-Hutchison
Oct 1, 1986·Agents and Actions·M A Bray
Jan 1, 1986·Archives of Dermatological Research·K IkaiS Narumiya
Apr 14, 1986·Biochemical and Biophysical Research Communications·P M Woollard
Apr 1, 1985·The Journal of Investigative Dermatology·E E OpasJ L Humes
Dec 1, 1985·The Journal of Investigative Dermatology·G D WeinsteinP A Ross
Nov 1, 1984·Journal of the American Academy of Dermatology·G G KruegerG D Weinstein
Jan 1, 1982·International Archives of Allergy and Applied Immunology·T Ruzicka, M P Printz
Oct 1, 1981·Journal of the American Academy of Dermatology·B A GilchrestM C Mihm

❮ Previous
Next ❯

Citations

Mar 12, 2004·Journal of Ethnopharmacology·Gurpreet KaurMohammad Athar
Oct 27, 1997·Journal of Pharmacological and Toxicological Methods·W E van den HovenH Timmerman
Nov 20, 1998·The Journal of Pharmacy and Pharmacology·M A FernándezM D García
Nov 1, 1995·Immunopharmacology and Immunotoxicology·A J Lewis, A F Keft
Jan 23, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Céline TryAlf Lamprecht
Jul 7, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·A Fernandez-ArcheM D Garcia
Aug 22, 2006·Basic & Clinical Pharmacology & Toxicology·Thomas K Petersen
Dec 1, 1989·Prostaglandins, Leukotrienes, and Essential Fatty Acids·D J Fretland, S W Djuric
Apr 24, 2012·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Anna Nicolaou
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·C QianC G Yeh
Jun 29, 2001·The Journal of Pharmacy and Pharmacology·M A FernándezM T Sáenz
Dec 6, 2001·The Journal of Pharmacy and Pharmacology·M A FernándezA Villar
Aug 21, 2013·JMIR Research Protocols·Sulafa KarimHendrik von Tengg-Kobligk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.